Literature DB >> 1281542

Secondary structure of Src homology 2 domain of c-Abl by heteronuclear NMR spectroscopy in solution.

M Overduin1, B Mayer, C B Rios, D Baltimore, D Cowburn.   

Abstract

The Src homology 2 (SH2) domain is a recognition motif thought to mediate the association of the cytoplasmic proteins involved in signal transduction by binding to phosphotyrosyl-containing sequences in proteins. Assignments of nearly all 1H and 15N resonances of the SH2 domain from the c-Abl protein-tyrosine kinase have been obtained from homonuclear and heteronuclear NMR experiments. The secondary structure has been elucidated from the pattern of nuclear Overhauser effects, from vicinal coupling constants, and from observation of slowly exchanging amino hydrogens. The secondary structure contains two alpha-helices and eight beta-strands, six of which are arranged in two contiguous, antiparallel beta-sheets. Residues believed to be involved in phosphotyrosyl ligand binding are on a face of one beta-sheet. The alignment of homologous sequences on the basis of secondary structure suggests a conserved global fold in a family of SH2 domains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281542      PMCID: PMC50618          DOI: 10.1073/pnas.89.24.11673

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Three-dimensional solution structure of the src homology 2 domain of c-abl.

Authors:  M Overduin; C B Rios; B J Mayer; D Baltimore; D Cowburn
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

2.  The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity.

Authors:  B J Mayer; P K Jackson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

3.  A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases.

Authors:  S H Shen; L Bastien; B I Posner; P Chrétien
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

Review 4.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

5.  Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src.

Authors:  H Hirai; H E Varmus
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

6.  Canonical structures for the hypervariable regions of immunoglobulins.

Authors:  C Chothia; A M Lesk
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

7.  Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.

Authors:  M Matsuda; B J Mayer; H Hanafusa
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

8.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.

Authors:  C A Koch; D Anderson; M F Moran; C Ellis; T Pawson
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

9.  Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways.

Authors:  W J Fantl; J A Escobedo; G A Martin; C W Turck; M del Rosario; F McCormick; L T Williams
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

10.  Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo.

Authors:  A Kashishian; A Kazlauskas; J A Cooper
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more
  6 in total

1.  Characterization of the Src/Abl hybrid kinase SmTK6 of Schistosoma mansoni.

Authors:  Svenja Beckmann; Steffen Hahnel; Katia Cailliau; Mathieu Vanderstraete; Edith Browaeys; Colette Dissous; Christoph G Grevelding
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

2.  The three-dimensional solution structure of the SRC homology domain-2 of the growth factor receptor-bound protein-2.

Authors:  M M Senior; A F Frederick; S Black; N J Murgolo; L M Perkins; O Wilson; M E Snow; Y S Wang
Journal:  J Biomol NMR       Date:  1998-02       Impact factor: 2.835

3.  A new point mutation involving a highly conserved leucine in the Btk SH2 domain in a family with X linked agammaglobulinaemia.

Authors:  Y Ohashi; S Tsuchiya; T Konno
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

4.  Chemical shift assignments and secondary structure of the Grb2 SH2 domain by heteronuclear NMR spectroscopy.

Authors:  Y S Wang; A F Frederick; M M Senior; B A Lyons; S Black; P Kirschmeier; L M Perkins; O Wilson
Journal:  J Biomol NMR       Date:  1996-03       Impact factor: 2.835

5.  Phosphoinositide, phosphopeptide and pyridone interactions of the Abl SH2 domain.

Authors:  Etienne Tokonzaba; Daniel G S Capelluto; Tatiana G Kutateladze; Michael Overduin
Journal:  Chem Biol Drug Des       Date:  2006-03       Impact factor: 2.817

6.  Binding of the Grb2 SH2 domain to phosphotyrosine motifs does not change the affinity of its SH3 domains for Sos proline-rich motifs.

Authors:  D Cussac; M Frech; P Chardin
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.